Fourniture de médicaments divers (sous-groupes ATC L01 et L04), formes injectables intraveineuses, à 4 établissements membres de la Fédération des Hôpitaux Luxembourgeois (AGANTI23).
UNKNOWN
OCID: ocds-70d2nz-839fe18e-abb6-47dd-a734-986ab30ff697 |
Release ID: 839fe18e-abb6-47dd-a734-986ab30ff697
L’objet du marché consiste dans la fourniture de médicaments divers (sous-groupes ATC L01 et L04), formes injectables intraveineuses. La description des fournitures demandées figure dans les documents de marché. Les établissements qui sont parties aux contrats conclus sont : - le Centre Hospitalier Émile Mayrisch (CHEM), - le Centre Hospitalier de Luxembourg (CHL), - le Centre Hospitalier du Nord (CHdN), et - les Hôpitaux Robert Schuman (HRS).
| Tender ID | 2023/S 60-176595 |
| Status | UNKNOWN |
| Procurement method | Open |
| Method details | pt_open |
| Main category | Goods |
| Award criteria | ratedCriteria |
| Number of tenderers | 1 |
| Tender period | — → Apr 27, 2023 |
| Published | Mar 24, 2023 |
| Lot ID | Title | Status | Value | Contract period |
|---|---|---|---|---|
lot-1 |
Vedolizumab | UNKNOWN | — | — |
lot-2 |
Pertuzumab | UNKNOWN | — | — |
lot-3 |
Obinutuzumab | UNKNOWN | — | — |
lot-4 |
Natalizumab | UNKNOWN | — | — |
lot-5 |
Elotuzumab | UNKNOWN | — | — |
lot-6 |
Carfilzomib | UNKNOWN | — | — |
lot-7 |
Brentuximab vedotin | UNKNOWN | — | — |
| Item ID | Description | Quantity | Related lot |
|---|---|---|---|
item-1 |
— | — | |
item-2 |
— | — | lot-1 |
item-3 |
— | — | lot-2 |
item-4 |
— | — | lot-3 |
item-5 |
— | — | lot-4 |
item-6 |
— | — | lot-5 |
item-7 |
— | — | lot-6 |
item-8 |
— | — | lot-7 |
Document
| Award ID | Title | Status | Value | Date |
|---|---|---|---|---|
award-2 |
— | UNKNOWN | 18 100 000,00 EUR | Jun 28, 2023 |
award-6 |
— | UNKNOWN | 18 100 000,00 EUR | May 17, 2023 |
award-1 |
— | UNKNOWN | 18 100 000,00 EUR | May 16, 2023 |
award-3 |
— | UNKNOWN | 18 100 000,00 EUR | May 16, 2023 |
award-4 |
— | UNKNOWN | 18 100 000,00 EUR | May 16, 2023 |
award-5 |
— | UNKNOWN | 375 000,00 EUR | May 16, 2023 |
award-7 |
— | UNKNOWN | 18 100 000,00 EUR | May 16, 2023 |
Fédération des hôpitaux luxembourgeois (FHL), association sans but lucratif
Buyer
ID: EU_body_589dd3d2a33d0e919fb8e3d820a760b8262a3a90728e69749435602f92059bca · carla.moreira@fhlux.lu
TAKEDA BELGIUM S.A.
Supplier
ID: EU_body_7294543d28f21895d96d03b8bb40aaa0052ae6e1d6147fe6c2d4e79c22a477f2
ROCHE S.A.
Supplier
ID: EU_body_eba189731c2b1d47f59d8d47e4670e388dc6e4be57fb6ed96a9045160d3596be
BIOGEN BELGIUM S.A.
Supplier
ID: EU_body_994289235b4b053451afdf798a5aa296364df425d265abc2d1ebe0d3dd015e37
Bristol-Myers Squibb Belgium SA
Supplier
ID: EU_body_7d4c25e02889915f75a2ddf2a78689d451c2af5f2a8840ca0668fd09696e1abd
AMGEN S.A.
Supplier
ID: EU_body_4307f08f42684ee7e5eea5d00f8cdd951cc2305d25f77167313aa6b1fc021865